glp-1 receptor agonists muscle mass preservation 2025 Balancing weight and loss in GLP1 agonist therapy Long-term Success of GLP-1s Hinges

In general, without knowing what Medicaid and Medicare generally are currently paying for these drugs on net, it is uncertain whether the lower prices that will be made available to state Medicaid programs and Part D plans under the BALANCE Model for currently covered uses of GLP-1s will generate enough savings to offset the additional costs from expanded use of these medications for obesity

Some orthopedic surgeons may perceive the growing use of GLP-1 receptor agonists as a potential threat to their practice, fearing that widespread weight loss could reduce the volume of patients requiring joint replacements

AOM, anti-obesity medication

Arq Bras Endocrinol Metabol 2013;57:702-708

Choose bland, protein-rich foods like eggs, plain chicken, protein shakes, or Greek yogurt